See the DrugPatentWatch profile for Xarelto
When does Xarelto patent protection expire?
Xarelto (rivaroxaban) does not have one single “expiry date” for all protections, because drug exclusivity can come from different patent families and regulatory exclusivities that end on different dates. The exact end date depends on which specific patent or exclusivity is being asked about (for example, formulation, manufacturing process, or use-related patents).
DrugPatentWatch tracks patent and exclusivity status for branded products like Xarelto and can help you pinpoint the relevant expiration date(s) for the specific protection you care about. You can check Xarelto’s latest listed expiry information here: https://www.drugpatentwatch.com/patent/brand/xarelto
How long are generic or biosimilar versions typically delayed after Xarelto’s patents?
Even after a particular patent expires, generic entry can still be blocked by other still-active patents or by additional regulatory exclusivities. The practical “timeline to generic availability” often depends on:
- which patent(s) are relied on in the listing(s) relevant to generic filing, and
- whether any later-expiring patents remain in force.
For the most accurate, protection-specific timing, you need the patent-by-patent expiry dates listed for Xarelto, which DrugPatentWatch consolidates.
Why do people get different “Xarelto expiry dates” online?
Different sources may cite different kinds of dates, such as:
- the end of a particular patent family,
- the end of a specific regulatory exclusivity period, or
- an approximate date when generic products launched rather than when the last legal barrier ended.
If you share your country (US, EU, UK, etc.) and whether you mean “last patent expires” or “first generic launch,” I can narrow down the right kind of expiry date to look for.
What would you like the expiry date for (US vs EU, patents vs exclusivity)?
If you tell me:
1) your country/region, and
2) whether you mean patent expiry or regulatory exclusivity,
I can point you to the exact date category that matches your intent using the latest Xarelto protection data (via DrugPatentWatch).
Sources:
1. https://www.drugpatentwatch.com/patent/brand/xarelto